Aldeyra Therapeutics, Inc. - Common Stock (ALDX)

CUSIP: 01438T106

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / Common Stock
Shares outstanding
59,794,743
Total 13F shares
4,372,667
Share change
-55,088
Total reported value
$18,317,243
Price per share
$4.19
Number of holders
26
Value change
-$231,292
Number of buys
10
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 01438T106?
CUSIP 01438T106 identifies ALDX - Aldeyra Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ALDX - Aldeyra Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
2.4%
1,437,811
$9,748,000 31 Dec 2015
13F
PERCEPTIVE ADVISORS LLC
13F
Company
2.1%
1,240,458
$8,410,000 31 Dec 2015
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
1.2%
690,538
$4,682,000 31 Dec 2015
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.4%
238,500
$1,617,000 31 Dec 2015
13F
BAKER BROS. ADVISORS LP
13F
Company
0.24%
142,000
$963,000 31 Dec 2015
13F
Knoll Capital Management, LLC
13F
Company
0.23%
135,800
$921,000 31 Dec 2015
13F
VANGUARD GROUP INC
13F
Company
0.2%
118,340
$802,000 31 Dec 2015
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.18%
110,024
$746,000 31 Dec 2015
13F
Weiss Multi-Strategy Advisers LLC
13F
Company
0.13%
76,000
$515,000 31 Dec 2015
13F
SABBY MANAGEMENT, LLC
13F
Company
0.11%
68,699
$466,000 31 Dec 2015
13F
Boxer Capital, LLC
13F
Company
0.11%
63,146
$428,000 31 Dec 2015
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.1%
57,500
$390,000 31 Dec 2015
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.04%
22,558
$152,000 31 Dec 2015
13F
NORTHERN TRUST CORP
13F
Company
0.02%
12,286
$83,000 31 Dec 2015
13F
MORGAN STANLEY
13F
Company
0.01%
7,222
$49,000 31 Dec 2015
13F
BLACKROCK ADVISORS LLC
13F
Company
0%
2,978
$20,000 31 Dec 2015
13F
Vantage Investment Advisors, LLC
13F
Company
0%
2,000
$14,000 31 Dec 2015
13F
BlackRock Investment Management, LLC
13F
Company
0%
958
$6,000 31 Dec 2015
13F
BlackRock Fund Advisors
13F
Company
0%
781
$5,000 31 Dec 2015
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
156
$1,000 31 Dec 2015
13F

Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock (ALDX) as of Q1 2016

As of 31 Mar 2016, Aldeyra Therapeutics, Inc. - Common Stock (ALDX) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,372,667 shares. The largest 10 holders included FMR LLC, PERCEPTIVE ADVISORS LLC, DEERFIELD MANAGEMENT CO, SPHERA FUNDS MANAGEMENT LTD., DAFNA Capital Management LLC, BAKER BROS. ADVISORS LP, Knoll Capital Management, LP, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, and Weiss Multi-Strategy Advisers LLC. This page lists 26 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2016 vs Q4 2015 Across Filers

Q4 2015 holders
20
Q1 2016 holders
26
Holder diff
6
Investor Q4 2015 Shares Q1 2016 Shares Share Diff Share Chg % Q4 2015 Value $ Q1 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.